UBS Group’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.8M Buy
68,300
+38,400
+128% +$3.52M ﹤0.01% 3779
2026
Q2
$2.87M Buy
+29,900
New +$2.73M ﹤0.01% 4759
2024
Q1
– Sell
-48,600
Closed -$1.29M – 9236
2023
Q4
$1.29M Buy
+48,600
New +$1.42M ﹤0.01% 4263

Other funds holding AEHR

UBS Group's AEHR Position: Q3 2026 in Review

UBS Group increased its Aehr Test Systems (AEHR) stake by 20% in Q3 2026, buying an estimated $3.18M and bringing the position to 203,788 shares worth $20.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

UBS Group first reported a position in AEHR in Q4 2014 and has held it in 32 quarters since. 298 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • UBS Group held 203,788 shares of Aehr Test Systems worth $20.3M as of Q3 2026.
  • UBS Group bought 34,665 Aehr Test Systems shares in Q3 2026, an estimated $3.18M.
  • Aehr Test Systems made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2648 holding.
  • UBS Group first reported a position in Aehr Test Systems in Q4 2014 and has held it in 32 quarters since.
  • 298 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.